Go-to-Market Strategy
Our service-based model reduces training needs and ensures consistent, accurate outcomes while lowering costs. Revenue grows by securing contracts with biotech and pharma firms. Initial costs rise but efficiency gains offset them over time. Revenue scales with contract acquisition, bolstered by streamlined processes and strategic partnerships for sustainable growth.
Production
For production, we adhere to ISO standards as a non-medical device per FDA guidelines. We perform manufacturing and experimentation in-house, ensuring consistency and reliability. We are B2B, and can provide customized service and comprehensive data analysis including imaging, gene expression analysis, signal analysis, scientific reports, and more.
Pricing
We have tiered, flexible customer pricing options tailored towards our clients needs. Screening services are contractually negotiated. Speak to our experts for more detailed pricing info!